Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against Gram-positive cocci

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 5, 1996, Pages 1011-1016

  Coque, Teresa M ^a   Singh, Kavindra V ^a   Murray, Barbara E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS; STREPTOCOCCUS;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; FLUOROQUINOLONES; GRAM-POSITIVE COCCI; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; STAPHYLOCOCCUS; TIME FACTORS;

EID: 0029903277     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.5.1011     Document Type: Article

References (11)

1. Domagala, J. M. (1994). Structure-activity and structure-side-effect relationships for the quinolone antibacterials. Journal of Antimicrobial Chemotherapy 33, 685-706.
2. Eliopoulos, G. M., Klimm, K., Eliopoulos, C. T., Ferraro, M. J. & Moellering, R. C. (1993). In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria. Antimicrobial Agents and Chemotherapy 37, 366-70.
3. Korten, V., Tomayko, J. F. & Murray, B. E. (1994). Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against Gram-positive cocci. Antimicrobial Agents and Chemotherapy 38, 611-5.
4. Moellering, R. C., Wennersten, C. & Weinberg, A. N. (1971). Studies on antibiotic synergism against enterococci. I. Bacteriologic studies. Journal of Laboratory and Clinical Medicine 77, 821-8.
5. National Committee for Clinical Laboratory Standards. (1992). Methods for Determining Bactericidal Activity of Antimicrobial Agents. Approved Standard M26-T. NCCLS, Villanova, PA.
6. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-AE. NCCLS, Villanova, PA.
7. Neu, H. C. & Chin, N. (1994). In vitro activity of the new fluoroquinolone CP-99,219. Antimicrobial Agents and Chemotherapy 38, 2615-22.
8. Perri, M. B., Chow, J. W. & Zervos, M. J. (1993). In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci. Diagnostic Microbiology and Infectious Disease 17, 151-5.
9. Piddock, L. J. V. (1994). New quinolones and Gram-positive bacteria. Antimicrobial Agents and Chemotherapy 38, 163-9.
10. Sahm, D. F. & Koburov, G. T. (1989). In vitro activies of quinolones against enterococci resistant to penicillin-aminoglycoside synergy. Antimicrobial Agents and Chemotherapy 33, 71-7.
11. Teng, R., Harris, S. C., Foulds, G., Silber, B. & Liston, T. E. (1995). Pharmacokinetics of CP-99,219, a new quinolone antibiotic, following single oral doses to healthy volunteers. In Program and Abstracts of the Seventh European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, 1995. Abstract 743.